Bayer lifts sales and earnings again
Interim report for the third quarter of 2010: Sales grow by 16.1 percent to EUR 8,581 million EBITDA before special items up 10.5 percent to EUR 1,656 million Core earnings per share increase by 21.8 percent to EUR 0.95 Provisions of EUR 436 million established for litigations Net financial debt reduced by EUR 1.6 billion to EUR 9.1 billion Group outlook for 2010 confirmed Lever...
Bayer: sales and EBIT at record levels
Financial and innovation targets for 2011 achievedLeverkusen, February 28, 2012 - The Bayer Group had a very successful year in 2011 both strategically and operationally, posting record levels of sales and EBIT. "We achieved the Group targets that we raised after the first quarter," said Bayer CEO Dr. Marijn Dekkers at the Financial News Conference in Leverkusen on Tuesday. The company also made g...